share_log
Moomoo 24/7 ·  03/12 06:38

KalVista Pharmaceuticals Announced The UK Medicines And Healthcare Products Regulatory Agency Has Awarded The Promising Innovative Medicine Designation For Sebetralstat For On-demand Treatment Of Hereditary Angioedema

KalVista 制药公司宣布,英国药品和保健产品监管局已授予用于按需治疗遗传性血管性水肿的 Sebetralstat 具有前景的创新药物称号

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发